SEC 13F Intelligence

Artal Group S.A. / SLN

Artal Group S.A.’s Silence Therapeutics PLC Position

Does Artal Group S.A. own Silence Therapeutics PLC (SLN)? Not currently — the last reported position was 2.78M shares worth $53M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$53M
Q2 2024
Shares
2.78M
% of Portfolio
+1.35%
Quarters Held
6
position exited

Position History SLN

Reported value by quarter
Q1 ’23: $3,131Q1 ’23Q2 ’23: $9,350Q2 ’23Q3 ’23: $24,550Q3 ’23Q4 ’23: $52,110Q4 ’23Q1 ’24: $60MQ1 ’24Q2 ’24: $53MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20242.78M$53M+1.35%
Q1 20242.78M$60M+1.53%
Q4 20233.00M$52,110+1.73%
Q3 20232.50M$24,550+1.05%
Q2 20231.70M$9,350+0.29%
Q1 2023505.1K$3,131+0.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artal Group S.A.’s full portfolio or all institutional holders of SLN.